Summary for Patients: Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Authors:

Published: 2020-06-01

DOI: 10.7326/p20-0008

Source: Full article

---

Abstract

No abstract found.